GenesisCare

Lumonus inks joint venture with NY cancer centre to scale AI oncology

Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.

Investment Notes: Lumonus

Investible announces it backed Lumonus' A$28 million round with three co-investors, the first deal from its new early-stage fund; Lumonus builds AI software that automates cancer clinic workflows.

Also SmartCompany·Forbes Australia

Brandon Capital news

Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.

Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Cut Through Venture·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·Forbes Australia·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com·Forbes Australia

eQALY is using tech to help elderly people to live at home for longer

Profile of eQALY, a care platform helping older people stay in their homes, covering Antler's recent investment, its pilot with an aged care provider, and co-founders Andy Laws and Kelly Tagalan.

Sugar-free drinks startup Nexba used crowdfunding to raise a quarter of its $6 million Series A round

Drinks brand Nexba closed a $6 million Series A, sourcing $1.5 million through VentureCrowd crowdfunding and the balance from private backers including River Capital and Gaingels, alongside other crowdfunding campaigns by Mungalli Creek Dairy and Supp.